KACZMAREK, F. and STEINEGGER, E. [Botanical classification and alkaloid content in the genus Lobelia.]. Pharm.Acta Helv. 1959;34:413-429. View abstract.
KACZMAREK, F. and STEINEGGER, E. [Paper chromatographic separation of the alkaloids of Lobelia inflata from lobinaline, the main alkaloid of Lobelia cardinalis.]. Pharm.Acta Helv. 1959;34:330-333. View abstract.
LENDLE, L. and RICHTER, R. [Pharmacologic analysis of the emetic and asthmalytic effects of Lobelia tinctures.]. Klin.Wochenschr. 10-15-1950;28(39-40):665-667. View abstract.
Lim, D. Y., Kim, Y. S., and Miwa, S. Influence of lobeline on catecholamine release from the isolated perfused rat adrenal gland. Auton.Neurosci. 1-30-2004;110(1):27-35. View abstract.
Lovkova, M. I., Buzuk, G. N., Sokolova, S. M., Kliment'eva, N. I., Ponomareva, S. M., Shelepova, O. V., and Vorotnitskaia, I. E. [Medicinal plants--concentrators of chromium. The role of chromium in alkaloid metabolism]. Izv.Akad.Nauk Ser.Biol. 1996;(5):552-564. View abstract.
Miller, D. K., Crooks, P. A., and Dwoskin, L. P. Lobeline inhibits nicotine-evoked [(3)H]dopamine overflow from rat striatal slices and nicotine-evoked (86)Rb(+) efflux from thalamic synaptosomes. Neuropharmacology 2000;39(13):2654-2662. View abstract.
Plakun, A. L., Ambrus, J., Bross, I., Graham, S., Levin, M. L., and Ross, C. A. Clinical factors in smoking withdrawal: preliminary report. Am J Public Health Nations.Health 1966;56(3):434-441. View abstract.
Shibano, M., Tsukamoto, D., Masuda, A., Tanaka, Y., and Kusano, G. Two new pyrrolidine alkaloids, radicamines A and B, as inhibitors of alpha-glucosidase from Lobelia chinensis Lour. Chem Pharm.Bull.(Tokyo) 2001;49(10):1362-1365. View abstract.
STEINEGGER, E. and EGGER, F. [Lophilin and lophilacrin, two new alkaloids from Lobelia.]. Pharm.Acta Helv. 8-31-1952;27(8):207-211. View abstract.
Subarnas, A., Oshima, Y., Sidik, and Ohizumi, Y. An antidepressant principle of Lobelia inflata L. (Campanulaceae). J Pharm.Sci. 1992;81(7):620-621. View abstract.
Subarnas, A., Tadano, T., Nakahata, N., Arai, Y., Kinemuchi, H., Oshima, Y., Kisara, K., and Ohizumi, Y. A possible mechanism of antidepressant activity of beta-amyrin palmitate isolated from Lobelia inflata leaves in the forced swimming test. Life Sci. 1993;52(3):289-296. View abstract.
Subarnas, A., Tadano, T., Oshima, Y., Kisara, K., and Ohizumi, Y. Pharmacological properties of beta-amyrin palmitate, a novel centrally acting compound, isolated from Lobelia inflata leaves. J Pharm.Pharmacol. 1993;45(6):545-550. View abstract.
Teng, L., Crooks, P. A., and Dwoskin, L. P. Lobeline displaces [3H]dihydrotetrabenazine binding and releases [3H]dopamine from rat striatal synaptic vesicles: comparison with d-amphetamine. J Neurochem. 1998;71(1):258-265. View abstract.
Weinges, K., Bahr, W., Ebert, W., and Kloss, P. [Norlobelanidine, the main alkaloid from Lobelia polyphylla Hook and Arn]. Justus.Liebigs Ann.Chem 1972;756:177-180. View abstract.
Hardman JG, Limbird LL, Molinoff PB, eds. Goodman and Gillman's The Pharmacological Basis of Therapeutics, 9th ed. New York, NY: McGraw-Hill, 1996.
McChargue DE, Collins FL Jr, Cohen LM. Effect of non-nicotinic moist snuff replacement and lobeline on withdrawal symptoms during 48-h smokeless tobacco deprivation. Nicotine Tob Res 2002;4:195-200. View abstract.
Stead LF, Hughes JR. Lobeline for smoking cessation. Cochrane Database Syst Rev 2000;2:CD000124. View abstract.
Davison, G. C. and Rosen, R. C. Lobeline and reduction of cigarette smoking. Psychol.Rep 1972;31(2):443-456. View abstract.
Dwoskin, L. P. and Crooks, P. A. A novel mechanism of action and potential use for lobeline as a treatment for psychostimulant abuse. Biochem.Pharmacol. 1-15-2002;63(2):89-98. View abstract.
Ikeda, K., Takahashi, M., Nishida, M., Miyauchi, M., Kizu, H., Kameda, Y., Arisawa, M., Watson, A. A., Nash, R. J., Fleet, G. W., and Asano, N. Homonojirimycin analogues and their glucosides from Lobelia sessilifolia and Adenophora spp. (Campanulaceae). Carbohydr.Res 1-12-2000;323(1-4):73-80. View abstract.